Regency Dialysis Center in Jacksonville, Florida - Dialysis Center

Regency Dialysis Center is a medicare approved dialysis facility center in Jacksonville, Florida and it has 16 dialysis stations. It is located in Duval county at 9535 Regency Square Blvd, Jacksonville, FL, 32225. You can reach out to the office of Regency Dialysis Center at (904) 725-0526. This dialysis clinic is managed and/or owned by Davita. Regency Dialysis Center has the following ownership type - Profit. It was first certified by medicare in September, 2007. The medicare id for this facility is 102850 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameRegency Dialysis Center
Location9535 Regency Square Blvd, Jacksonville, Florida
No. of Dialysis Stations 16
Medicare ID102850
Managed ByDavita
Ownership TypeProfit
Late Shifts Yes

Contact Information


9535 Regency Square Blvd, Jacksonville, Florida, 32225
(904) 725-0526

News Archive

Miracle camp for child burn victims

Miracle Burn Camp of Iowa began in 1995 as a one-day outing for children ages 8 to 18 with burn injuries. It evolved into a weeklong event and is jointly sponsored by St. Luke's Burn and Wound Center in Sioux City, and Children's Hospital of Iowa Burn Treatment Center at UI Hospitals and Clinics in Iowa City.

Type-3 polio virus case in Pakistan raises concerns of disease spreading, WHO says

Pakistan has reported the first case of the type-3 wild polio virus in six months, raising concerns that the disease may spread to other parts of Asia and beyond, the WHO said on Thursday, Bloomberg/San Francisco Chronicle reports.

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

Drug industry news: FDA again offers warning about a Dallas compounding pharmacy; more on Sovaldi

For the third time in 15 months, the FDA is warning health care providers and consumers not to use drugs that were made by a Dallas compounder because the medicines may be contaminated. And the ongoing struggle between the agency and NuVision Pharmacy underscores the difficulties that beset the pharmaceutical supply chain despite a recently passed law designed to bolster safety (Silverman, 7/21).

Read more Medical News

› Verified 3 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Regency Dialysis Center from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1821291147
Organization NameRegency Dialysis Center
Doing Business AsTotal Renal Care Inc
Address9535 Regency Square Blvd N Jacksonville, Florida, 32225
Phone Number(904) 725-0526

News Archive

Miracle camp for child burn victims

Miracle Burn Camp of Iowa began in 1995 as a one-day outing for children ages 8 to 18 with burn injuries. It evolved into a weeklong event and is jointly sponsored by St. Luke's Burn and Wound Center in Sioux City, and Children's Hospital of Iowa Burn Treatment Center at UI Hospitals and Clinics in Iowa City.

Type-3 polio virus case in Pakistan raises concerns of disease spreading, WHO says

Pakistan has reported the first case of the type-3 wild polio virus in six months, raising concerns that the disease may spread to other parts of Asia and beyond, the WHO said on Thursday, Bloomberg/San Francisco Chronicle reports.

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

Drug industry news: FDA again offers warning about a Dallas compounding pharmacy; more on Sovaldi

For the third time in 15 months, the FDA is warning health care providers and consumers not to use drugs that were made by a Dallas compounder because the medicines may be contaminated. And the ongoing struggle between the agency and NuVision Pharmacy underscores the difficulties that beset the pharmaceutical supply chain despite a recently passed law designed to bolster safety (Silverman, 7/21).

Read more Medical News

› Verified 3 days ago


Survey of Patient's Experiences

Nephrologists Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that nephrologists always communicated and cared for them.75%67%
Patients who reported that nephrologists usually communicated and cared for them.13%15%
Patients who reported that nephrologists sometimes or never communicated and cared for them.12%18%
Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).74%60%
Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).16%26%
Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).10%14%

News Archive

Miracle camp for child burn victims

Miracle Burn Camp of Iowa began in 1995 as a one-day outing for children ages 8 to 18 with burn injuries. It evolved into a weeklong event and is jointly sponsored by St. Luke's Burn and Wound Center in Sioux City, and Children's Hospital of Iowa Burn Treatment Center at UI Hospitals and Clinics in Iowa City.

Type-3 polio virus case in Pakistan raises concerns of disease spreading, WHO says

Pakistan has reported the first case of the type-3 wild polio virus in six months, raising concerns that the disease may spread to other parts of Asia and beyond, the WHO said on Thursday, Bloomberg/San Francisco Chronicle reports.

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

Drug industry news: FDA again offers warning about a Dallas compounding pharmacy; more on Sovaldi

For the third time in 15 months, the FDA is warning health care providers and consumers not to use drugs that were made by a Dallas compounder because the medicines may be contaminated. And the ongoing struggle between the agency and NuVision Pharmacy underscores the difficulties that beset the pharmaceutical supply chain despite a recently passed law designed to bolster safety (Silverman, 7/21).

Read more Medical News

› Verified 3 days ago

Dialysis Center Staff Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible.74%62%
Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible.12%20%
Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free.14%18%
Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).72%62%
Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).13%26%
Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).15%12%

News Archive

Miracle camp for child burn victims

Miracle Burn Camp of Iowa began in 1995 as a one-day outing for children ages 8 to 18 with burn injuries. It evolved into a weeklong event and is jointly sponsored by St. Luke's Burn and Wound Center in Sioux City, and Children's Hospital of Iowa Burn Treatment Center at UI Hospitals and Clinics in Iowa City.

Type-3 polio virus case in Pakistan raises concerns of disease spreading, WHO says

Pakistan has reported the first case of the type-3 wild polio virus in six months, raising concerns that the disease may spread to other parts of Asia and beyond, the WHO said on Thursday, Bloomberg/San Francisco Chronicle reports.

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

Drug industry news: FDA again offers warning about a Dallas compounding pharmacy; more on Sovaldi

For the third time in 15 months, the FDA is warning health care providers and consumers not to use drugs that were made by a Dallas compounder because the medicines may be contaminated. And the ongoing struggle between the agency and NuVision Pharmacy underscores the difficulties that beset the pharmaceutical supply chain despite a recently passed law designed to bolster safety (Silverman, 7/21).

Read more Medical News

› Verified 3 days ago

Overall Dialysis Center Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. 82%80%
Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them.18%20%
Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).75%68%
Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).9%20%
Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).16%12%

News Archive

Miracle camp for child burn victims

Miracle Burn Camp of Iowa began in 1995 as a one-day outing for children ages 8 to 18 with burn injuries. It evolved into a weeklong event and is jointly sponsored by St. Luke's Burn and Wound Center in Sioux City, and Children's Hospital of Iowa Burn Treatment Center at UI Hospitals and Clinics in Iowa City.

Type-3 polio virus case in Pakistan raises concerns of disease spreading, WHO says

Pakistan has reported the first case of the type-3 wild polio virus in six months, raising concerns that the disease may spread to other parts of Asia and beyond, the WHO said on Thursday, Bloomberg/San Francisco Chronicle reports.

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

Drug industry news: FDA again offers warning about a Dallas compounding pharmacy; more on Sovaldi

For the third time in 15 months, the FDA is warning health care providers and consumers not to use drugs that were made by a Dallas compounder because the medicines may be contaminated. And the ongoing struggle between the agency and NuVision Pharmacy underscores the difficulties that beset the pharmaceutical supply chain despite a recently passed law designed to bolster safety (Silverman, 7/21).

Read more Medical News

› Verified 3 days ago

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data38
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL29

News Archive

Miracle camp for child burn victims

Miracle Burn Camp of Iowa began in 1995 as a one-day outing for children ages 8 to 18 with burn injuries. It evolved into a weeklong event and is jointly sponsored by St. Luke's Burn and Wound Center in Sioux City, and Children's Hospital of Iowa Burn Treatment Center at UI Hospitals and Clinics in Iowa City.

Type-3 polio virus case in Pakistan raises concerns of disease spreading, WHO says

Pakistan has reported the first case of the type-3 wild polio virus in six months, raising concerns that the disease may spread to other parts of Asia and beyond, the WHO said on Thursday, Bloomberg/San Francisco Chronicle reports.

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

Drug industry news: FDA again offers warning about a Dallas compounding pharmacy; more on Sovaldi

For the third time in 15 months, the FDA is warning health care providers and consumers not to use drugs that were made by a Dallas compounder because the medicines may be contaminated. And the ongoing struggle between the agency and NuVision Pharmacy underscores the difficulties that beset the pharmaceutical supply chain despite a recently passed law designed to bolster safety (Silverman, 7/21).

Read more Medical News

› Verified 3 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center72
    Adult patient months included in Kt/V greater than or equal to 1.2573
    Percentage of adult patients getting regular hemodialysis at the center97
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Miracle camp for child burn victims

    Miracle Burn Camp of Iowa began in 1995 as a one-day outing for children ages 8 to 18 with burn injuries. It evolved into a weeklong event and is jointly sponsored by St. Luke's Burn and Wound Center in Sioux City, and Children's Hospital of Iowa Burn Treatment Center at UI Hospitals and Clinics in Iowa City.

    Type-3 polio virus case in Pakistan raises concerns of disease spreading, WHO says

    Pakistan has reported the first case of the type-3 wild polio virus in six months, raising concerns that the disease may spread to other parts of Asia and beyond, the WHO said on Thursday, Bloomberg/San Francisco Chronicle reports.

    Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

    Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

    Drug industry news: FDA again offers warning about a Dallas compounding pharmacy; more on Sovaldi

    For the third time in 15 months, the FDA is warning health care providers and consumers not to use drugs that were made by a Dallas compounder because the medicines may be contaminated. And the ongoing struggle between the agency and NuVision Pharmacy underscores the difficulties that beset the pharmaceutical supply chain despite a recently passed law designed to bolster safety (Silverman, 7/21).

    Read more Medical News

    › Verified 3 days ago

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center4
    Adult patient months included in Kt/V greater than or equal to 1.731
    Percentage of adult patients getting regular peritoneal dialysis at the center
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

    News Archive

    Miracle camp for child burn victims

    Miracle Burn Camp of Iowa began in 1995 as a one-day outing for children ages 8 to 18 with burn injuries. It evolved into a weeklong event and is jointly sponsored by St. Luke's Burn and Wound Center in Sioux City, and Children's Hospital of Iowa Burn Treatment Center at UI Hospitals and Clinics in Iowa City.

    Type-3 polio virus case in Pakistan raises concerns of disease spreading, WHO says

    Pakistan has reported the first case of the type-3 wild polio virus in six months, raising concerns that the disease may spread to other parts of Asia and beyond, the WHO said on Thursday, Bloomberg/San Francisco Chronicle reports.

    Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

    Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

    Drug industry news: FDA again offers warning about a Dallas compounding pharmacy; more on Sovaldi

    For the third time in 15 months, the FDA is warning health care providers and consumers not to use drugs that were made by a Dallas compounder because the medicines may be contaminated. And the ongoing struggle between the agency and NuVision Pharmacy underscores the difficulties that beset the pharmaceutical supply chain despite a recently passed law designed to bolster safety (Silverman, 7/21).

    Read more Medical News

    › Verified 3 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Regency Dialysis Center with elevated calcium levels.

Patients with hypercalcemia78
Hypercalcemia patient months641
Hypercalcemia patients with serumcalcium greater than 10.2 mg1
Patients with Serumphosphor79
Patients with Serumphosphor less than 3.5 mg/dL9
Patients with Serumphosphor from 3.5 to 4.5 mg/dL23
Patients with Serumphosphor from 4.6 to 5.5 mg/dL33
Patients with Serumphosphor from 5.6 to 7 mg/dL21
Patients with Serumphosphor greater than 7 mg/dL15

News Archive

Miracle camp for child burn victims

Miracle Burn Camp of Iowa began in 1995 as a one-day outing for children ages 8 to 18 with burn injuries. It evolved into a weeklong event and is jointly sponsored by St. Luke's Burn and Wound Center in Sioux City, and Children's Hospital of Iowa Burn Treatment Center at UI Hospitals and Clinics in Iowa City.

Type-3 polio virus case in Pakistan raises concerns of disease spreading, WHO says

Pakistan has reported the first case of the type-3 wild polio virus in six months, raising concerns that the disease may spread to other parts of Asia and beyond, the WHO said on Thursday, Bloomberg/San Francisco Chronicle reports.

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

Drug industry news: FDA again offers warning about a Dallas compounding pharmacy; more on Sovaldi

For the third time in 15 months, the FDA is warning health care providers and consumers not to use drugs that were made by a Dallas compounder because the medicines may be contaminated. And the ongoing struggle between the agency and NuVision Pharmacy underscores the difficulties that beset the pharmaceutical supply chain despite a recently passed law designed to bolster safety (Silverman, 7/21).

Read more Medical News

› Verified 3 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 117
Patient months included in arterial venous fistula and catheter summaries 532
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment65
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer10

News Archive

Miracle camp for child burn victims

Miracle Burn Camp of Iowa began in 1995 as a one-day outing for children ages 8 to 18 with burn injuries. It evolved into a weeklong event and is jointly sponsored by St. Luke's Burn and Wound Center in Sioux City, and Children's Hospital of Iowa Burn Treatment Center at UI Hospitals and Clinics in Iowa City.

Type-3 polio virus case in Pakistan raises concerns of disease spreading, WHO says

Pakistan has reported the first case of the type-3 wild polio virus in six months, raising concerns that the disease may spread to other parts of Asia and beyond, the WHO said on Thursday, Bloomberg/San Francisco Chronicle reports.

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

Drug industry news: FDA again offers warning about a Dallas compounding pharmacy; more on Sovaldi

For the third time in 15 months, the FDA is warning health care providers and consumers not to use drugs that were made by a Dallas compounder because the medicines may be contaminated. And the ongoing struggle between the agency and NuVision Pharmacy underscores the difficulties that beset the pharmaceutical supply chain despite a recently passed law designed to bolster safety (Silverman, 7/21).

Read more Medical News

› Verified 3 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary73
Hospitalization Rate in facility304.9 (Worse than Expected)
Hospitalization Rate: Upper Confidence Limit465.5
Hospitalization Rate: Lower Confidence Limit204.3

News Archive

Miracle camp for child burn victims

Miracle Burn Camp of Iowa began in 1995 as a one-day outing for children ages 8 to 18 with burn injuries. It evolved into a weeklong event and is jointly sponsored by St. Luke's Burn and Wound Center in Sioux City, and Children's Hospital of Iowa Burn Treatment Center at UI Hospitals and Clinics in Iowa City.

Type-3 polio virus case in Pakistan raises concerns of disease spreading, WHO says

Pakistan has reported the first case of the type-3 wild polio virus in six months, raising concerns that the disease may spread to other parts of Asia and beyond, the WHO said on Thursday, Bloomberg/San Francisco Chronicle reports.

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

Drug industry news: FDA again offers warning about a Dallas compounding pharmacy; more on Sovaldi

For the third time in 15 months, the FDA is warning health care providers and consumers not to use drugs that were made by a Dallas compounder because the medicines may be contaminated. And the ongoing struggle between the agency and NuVision Pharmacy underscores the difficulties that beset the pharmaceutical supply chain despite a recently passed law designed to bolster safety (Silverman, 7/21).

Read more Medical News

› Verified 3 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Regency Dialysis Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility23.7 (As Expected)
Readmission Rate: Upper Confidence Limit31.8
Readmission Rate: Lower Confidence Limit16.8

News Archive

Miracle camp for child burn victims

Miracle Burn Camp of Iowa began in 1995 as a one-day outing for children ages 8 to 18 with burn injuries. It evolved into a weeklong event and is jointly sponsored by St. Luke's Burn and Wound Center in Sioux City, and Children's Hospital of Iowa Burn Treatment Center at UI Hospitals and Clinics in Iowa City.

Type-3 polio virus case in Pakistan raises concerns of disease spreading, WHO says

Pakistan has reported the first case of the type-3 wild polio virus in six months, raising concerns that the disease may spread to other parts of Asia and beyond, the WHO said on Thursday, Bloomberg/San Francisco Chronicle reports.

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

Drug industry news: FDA again offers warning about a Dallas compounding pharmacy; more on Sovaldi

For the third time in 15 months, the FDA is warning health care providers and consumers not to use drugs that were made by a Dallas compounder because the medicines may be contaminated. And the ongoing struggle between the agency and NuVision Pharmacy underscores the difficulties that beset the pharmaceutical supply chain despite a recently passed law designed to bolster safety (Silverman, 7/21).

Read more Medical News

› Verified 3 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Regency Dialysis Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility1.67 (As Expected)
SIR: Upper Confidence Limit3.48
SIR: Lower Confidence Limit.68

News Archive

Miracle camp for child burn victims

Miracle Burn Camp of Iowa began in 1995 as a one-day outing for children ages 8 to 18 with burn injuries. It evolved into a weeklong event and is jointly sponsored by St. Luke's Burn and Wound Center in Sioux City, and Children's Hospital of Iowa Burn Treatment Center at UI Hospitals and Clinics in Iowa City.

Type-3 polio virus case in Pakistan raises concerns of disease spreading, WHO says

Pakistan has reported the first case of the type-3 wild polio virus in six months, raising concerns that the disease may spread to other parts of Asia and beyond, the WHO said on Thursday, Bloomberg/San Francisco Chronicle reports.

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

Drug industry news: FDA again offers warning about a Dallas compounding pharmacy; more on Sovaldi

For the third time in 15 months, the FDA is warning health care providers and consumers not to use drugs that were made by a Dallas compounder because the medicines may be contaminated. And the ongoing struggle between the agency and NuVision Pharmacy underscores the difficulties that beset the pharmaceutical supply chain despite a recently passed law designed to bolster safety (Silverman, 7/21).

Read more Medical News

› Verified 3 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Regency Dialysis Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 64
Transfusion Rate in facility64.4 (As Expected)
Transfusion Rate: Upper Confidence Limit136.7
Transfusion Rate: Lower Confidence Limit33.3

News Archive

Miracle camp for child burn victims

Miracle Burn Camp of Iowa began in 1995 as a one-day outing for children ages 8 to 18 with burn injuries. It evolved into a weeklong event and is jointly sponsored by St. Luke's Burn and Wound Center in Sioux City, and Children's Hospital of Iowa Burn Treatment Center at UI Hospitals and Clinics in Iowa City.

Type-3 polio virus case in Pakistan raises concerns of disease spreading, WHO says

Pakistan has reported the first case of the type-3 wild polio virus in six months, raising concerns that the disease may spread to other parts of Asia and beyond, the WHO said on Thursday, Bloomberg/San Francisco Chronicle reports.

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

Drug industry news: FDA again offers warning about a Dallas compounding pharmacy; more on Sovaldi

For the third time in 15 months, the FDA is warning health care providers and consumers not to use drugs that were made by a Dallas compounder because the medicines may be contaminated. And the ongoing struggle between the agency and NuVision Pharmacy underscores the difficulties that beset the pharmaceutical supply chain despite a recently passed law designed to bolster safety (Silverman, 7/21).

Read more Medical News

› Verified 3 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Regency Dialysis Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary417
Mortality Rate in facility21.5 (As Expected)
Mortality Rate: Upper Confidence Limit28
Mortality Rate: Lower Confidence Limit16.2

News Archive

Miracle camp for child burn victims

Miracle Burn Camp of Iowa began in 1995 as a one-day outing for children ages 8 to 18 with burn injuries. It evolved into a weeklong event and is jointly sponsored by St. Luke's Burn and Wound Center in Sioux City, and Children's Hospital of Iowa Burn Treatment Center at UI Hospitals and Clinics in Iowa City.

Type-3 polio virus case in Pakistan raises concerns of disease spreading, WHO says

Pakistan has reported the first case of the type-3 wild polio virus in six months, raising concerns that the disease may spread to other parts of Asia and beyond, the WHO said on Thursday, Bloomberg/San Francisco Chronicle reports.

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

Drug industry news: FDA again offers warning about a Dallas compounding pharmacy; more on Sovaldi

For the third time in 15 months, the FDA is warning health care providers and consumers not to use drugs that were made by a Dallas compounder because the medicines may be contaminated. And the ongoing struggle between the agency and NuVision Pharmacy underscores the difficulties that beset the pharmaceutical supply chain despite a recently passed law designed to bolster safety (Silverman, 7/21).

Read more Medical News

› Verified 3 days ago


Dialysis Facility in Jacksonville, FL

Shands Jacksonville - Esrd
Location: 655 W 8th St, Jacksonville, Florida, 32209
Phone: (904) 244-5448
Baptist Medical Center - Pediatric Dialysis
Location: 800 Prudential Dr, Jacksonville, Florida, 32207
Phone: (904) 202-0436
Dialysis Clinic Inc
Location: 757 Union Street W, Jacksonville, Florida, 32202
Phone: (904) 354-0409
FMC Dialysis Services - North Jacksonville
Location: 10614 Lem Turner Rd, Jacksonville, Florida, 32218
Phone: (904) 768-8576
BMA - Jacksonville
Location: 1944 Atlantic Blvd, Jacksonville, Florida, 32207
Phone: (904) 396-7203

News Archive

Miracle camp for child burn victims

Miracle Burn Camp of Iowa began in 1995 as a one-day outing for children ages 8 to 18 with burn injuries. It evolved into a weeklong event and is jointly sponsored by St. Luke's Burn and Wound Center in Sioux City, and Children's Hospital of Iowa Burn Treatment Center at UI Hospitals and Clinics in Iowa City.

Type-3 polio virus case in Pakistan raises concerns of disease spreading, WHO says

Pakistan has reported the first case of the type-3 wild polio virus in six months, raising concerns that the disease may spread to other parts of Asia and beyond, the WHO said on Thursday, Bloomberg/San Francisco Chronicle reports.

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

Drug industry news: FDA again offers warning about a Dallas compounding pharmacy; more on Sovaldi

For the third time in 15 months, the FDA is warning health care providers and consumers not to use drugs that were made by a Dallas compounder because the medicines may be contaminated. And the ongoing struggle between the agency and NuVision Pharmacy underscores the difficulties that beset the pharmaceutical supply chain despite a recently passed law designed to bolster safety (Silverman, 7/21).

Read more Medical News

› Verified 3 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.